Global Health Limited has released its Annual Secretarial Compliance Report for the financial year ending March 31, 2026. The report confirms that the company has largely adhered to all applicable corporate governance standards and procedural requirements. A minor procedural observation regarding the timing of financial result disclosures was noted and rectified by the company, ensuring complete transparency and alignment with best corporate practices for the reported period.
Report Overview
Global Health Limited, operating under the brand name Medanta, has published its comprehensive Secretarial Compliance Report for the financial year 2025-26. This document provides an independent review of the company’s commitment to statutory compliance and rigorous corporate governance protocols. The review was conducted by M/s. MAKS & CO., affirming the company’s adherence to its legal and operational responsibilities.
Compliance and Governance Highlights
The review confirms that Global Health Limited has maintained high standards across various critical areas, including:
- Board Performance: The company successfully conducted performance evaluations for the Board, its independent directors, and various committees at the beginning of the financial year.
- Website Transparency: The company maintains a functional, updated website ensuring the timely dissemination of all essential documents and information to stakeholders.
- Policy Integrity: All internal policies remain in full conformity with regulatory standards, having undergone timely reviews and updates.
- Transaction Oversight: All related party transactions were processed through the Audit Committee for prior approval, ensuring financial accountability.
Operational Observations
During the review, the auditor noted a minor administrative observation regarding the timeline between the approval of the FY 2024-25 audited financial results and their submission. Global Health Limited acknowledged this observation and ensured that all subsequent filings for FY 2025-26 were submitted within the prescribed 60-day window from the end of the financial year. The company remains committed to maintaining strict adherence to all disclosure requirements moving forward.
Source: BSE
